There are four different types of PPTA membership: Global, Regional, Source, and Associate.
Global membership is available to businesses or groups of businesses engaged in the manufacture of plasma protein therapies that meet the following criteria:
Regional membership (i.e., Europe, North America) is available and limited to businesses or groups of businesses engaged in the manufacture of products in two or fewer continents that meet each of the following criteria:
Source Membership is available to organizations engaged in the collecting, manufacturing, processing or distributing of plasma for further manufacture and that adhere to the highest standards of conduct as described in the Code of Ethics.
Associate Membership is available to organizations or groups of organizations providing services to businesses or organizations that qualify for either Global, Regional or Source membership in the Association. Associate members shall not be eligible to vote on Association matters or to hold office as directors or officers of the Association.
For information on how to become a member of PPTA, contact the Membership Services office of PPTA, by calling 202-789-3100 or by emailing email@example.com.
On March 16, PPTA published its 2021 Annual Report, providing an overview of the Association’s activities throughout the year. This year’s digital report offers readers an engaging and interactive experience as they read about PPTA’s work on behalf of its global membership and in support of patients who rely on plasma-derived therapies. We invite you to read the report here.Read More
The Plasma Protein Therapeutics Association (PPTA) expresses serious concern about the ongoing hostilities in Ukraine and the devastating impact on the lives of people in the region. As an association representing plasma collectors and manufacturers dedicated to saving and improving human lives, our primary focus remains on ensuring that patients have access to the essential plasma-derived treatments they rely on. Our member companies are making every effort to secure access for patients in the affected region during the conflict and in its aftermath.Read More
Dear PPTA Members and Patient Stakeholders,
We are writing to you today to inform you that Amy Efantis, PPTA’s president & CEO, recently informed the Global Board of Directors of her decision to leave the association. Her last day was Tuesday, February 15. We appreciate Amy’s contributions to PPTA in her time leading the association and wish her well in her future pursuits.Read More
The Plasma Protein Therapeutics Association (PPTA) disagrees with the 15 February 2022 ruling from the Romanian Competition Council (RCC) finding that PPTA directed manufacturers to withhold immunoglobulin (Ig) therapies from the Romanian market to force repeal of the so-called “clawback” tax. This conclusion is not supported by the RCC’s own investigation, which produced no evidence that company withdrawals from the Romanian market were the result of anything other than independent business decisions.Read More
The need for plasma and plasma donors is more urgent than ever before. Visit givingplasma.org to learn more and to find a donation center near you.